Sjögren’s syndrome
Alan Baer, MD,FACP,MACR
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); iCell Gene Therapeutics: Consultant (Terminated)
George A. W. Bruyn, MD,PhD,MACR
Reumakliniek Lelystad
Loenga, Netherlands
Disclosure(s): No financial relationships with ineligible companies to disclose
Alojzija Hocevar, MD,PhD
University Medical Center Ljubljana
LJUBLJANA, Slovenia
Disclosure(s): No financial relationships with ineligible companies to disclose
Diagnosis and treatment options for Sjögren's continue to challenge physicians. This session will cover novel therapeutics based on imaging advances that can help better diagnose and manage patients with Sjögren's, and discuss indications for acquiring histopathology and appropriate interpretation to guide therapy.
Speaker: Alan Baer, MD,FACP,MACR – Johns Hopkins University School of Medicine
Speaker: Alojzija Hocevar, MD,PhD – University Medical Center Ljubljana
Speaker: George A. W. Bruyn, MD,PhD,MACR – Reumakliniek Lelystad